1 study found for:    PANCREATIC GS 6624 MARYLAND
Show Display Options
RSS Create an RSS feed from your search for:
PANCREATIC GS 6624 MARYLAND
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Simtuzumab;   Drug: Gemcitabine;   Drug: Placebo to match simtuzumab

Indicates status has not been verified in more than two years